A press release reports that the FDA has cleared a suite of algorithms that, when combined with Eko’s digital stethoscopes, will enable healthcare providers in the USA to more accurately screen for heart conditions during routine physical exams. If left undiagnosed, these heart conditions can lead to stroke and heart failure. According to the [...]
Eko DUO digital stethoscope Eko has announced that the FDA has granted the company breakthrough status for its ECG-based algorithm that is designed to provides easily accessible screening test for heart failure. A press release reports that the algorithm analyses 15 seconds of ECG data collected from the Eko DUO digital stethoscope during [...]
Eko has secured $20 million in Series B funding. Led by ARTIS Ventures, according to a press release, the funding will drive further research and development and commercialisation of Eko’s machine learning platform for cardiac screening and analysis. Additional new and returning investors in the round include DigiTx Partners, NTT Venture Capital (NTTVC), 3M [...]